The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Open accessPublished version of a preprint
Abstract
SARS-CoV-2 is thought to have emerged from bats, possibly via a secondary host. Here, we investigate the relationship of spike (S) glycoprotein from SARS-CoV-2 with the S protein of a closely related bat virus, RaTG13. We determined cryo-EM structures for RaTG13 S and for both furin-cleaved and uncleaved SARS-CoV-2 S; we compared these with recently reported structures for uncleaved SARS-CoV-2 S. We also biochemically characterized their relative stabilities and affinities for the SARS-CoV-2 receptor ACE2. Although the overall structures of human and bat virus S proteins are similar, there are key differences in their properties, including a more stable precleavage form of human S and about 1,000-fold tighter binding of SARS-CoV-2 to human receptor. These observations suggest that cleavage at the furin-cleavage site decreases the overall stability of SARS-CoV-2 S and facilitates the adoption of the open conformation that is required for S to bind to the ACE2 receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, a loss-of-function modification or deletion of the furin cleavage site of the S protein in vaccine development can be beneficial.70,71”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chan, C.-M., Woo, P. C. Y., Lau, S. K. P., Tse, H., Chen, H., Li, F., Zheng, B.-J., Chen, L., Huang, J., & Yuen, K. (2008) · Experimental Biology and Medicine · doi:10.3181/0806-rm-197 · Cited by 41
RetractedFeatures and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
Research works printed but not linked: 1
- Masters, P. S. & Perlman S. in Fields Virology 6th edn, Vol. 1 (eds Howley, P. M. & Knipe, D. M.) 825–858 (Lippincott Williams & Wilkins, 2013).
Cited by
Sorted by citations
Items 101–200 of 544
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
Dong, J., Zost, S. J., Greaney, A. J., Starr, T. N., Dingens, A. S., Chen, E. C., Chen, R. E., Case, J. B., Sutton, R. E., Gilchuk, P., et al. (2021) · doi:10.1101/2021.01.27.428529 · Cited by 55
Finkelstein, M. T., Mermelstein, A. G., Miller, E. P., Seth, P. C., Stancofski, E.-S. D., & Fera, D. (2021) · Viruses · doi:10.3390/v13010134 · Cited by 63
Staquicini, D. I., Tang, F. H. F., Markosian, C., Yao, V. J., Staquicini, F. I., Dodero‐Rojas, E., Contessoto, V. G., Davis, D., O’Brien, P., Habib, N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105739118 · Cited by 69
Yang, T., Yu, P., Chang, Y., Kuo, C., Khoo, K., & Hsu, S. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101238 · Cited by 63
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification
Rosen, L. E., Tortorici, M. A., Marco, A. D., Pinto, D., Foreman, W. B., Taylor, A. L., Park, Y., Bohan, D., Rietz, T. A., Errico, J. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.026 · Cited by 67
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Rapp, M., Guo, Y., Reddem, E. R., Yu, J., Liu, L., Wang, P., Cerutti, G., Katsamba, P. S., Bimela, J. S., Bahna, F. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108950 · Cited by 59
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Greaney, A. J., Starr, T. N., Eguia, R. T., Loes, A. N., Khan, K., Karim, F., Cele, S., Bowen, J. E., Logue, J. K., Corti, D., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010248 · Cited by 58
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Liu, W., Huang, Z., Xiao, J., Wu, Y., Xia, N., & Yuan, Q. (2024) · Viruses · doi:10.3390/v16020184 · Cited by 68
Liu, X.-Q., Luongo, C., Matsuoka, Y., Park, H.-S., Santos, C., Yang, L.-J., Moore, I. N., Afroz, S., Johnson, R. F., Lafont, B., et al. (2021) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2109744118 · Cited by 60
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Kastenhuber, E. R., Mercadante, M., Nilsson-Payant, B. E., Johnson, J. L., Jaimes, J. A., Muecksch, F., Weisblum, Y., Bram, Y., Chandar, V., Whittaker, G. R., et al. (2022) · eLife · doi:10.7554/elife.77444 · Cited by 61
Haynes, W. A., Kamath, K., Bozekowski, J. D., Baum, E., Campbell, M., Casanovas‐Massana, A., Daugherty, P. S., Cruz, C. S. D., Dhal, A., Farhadian, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02835-2 · Cited by 60
Lim, K., Nishide, G., Yoshida, T., Watanabe‐Nakayama, T., Kobayashi, A., Hazawa, M., Hanayama, R., Ando, T., & Wong, R. W.-C. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12170 · Cited by 56
Feldman, J. E., Bals, J., Altomare, C. G., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl5842 · Cited by 60
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Zhang, N.-N., Zhang, R.-R., Zhang, Y.-F., Ji, K., Xiong, X.-C., Qin, Q.-S., Gao, P., Lu, X.-S., Zhou, H.-Y., Song, H.-F., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00626-w · Cited by 47
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Chen, Y. Z., Liu, Q., Zhou, L., Zhou, Y., Yan, H., & Lan, K. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100029 · Cited by 58
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj9815 · Cited by 56
Expression and characterization of SARS-CoV-2 spike proteins
Schaub, J. M., Chou, C., Kuo, H., Javanmardi, K., Hsieh, C., Goldsmith, J. A., DiVenere, A. M., Le, K. C., Wrapp, D., Byrne, P. O., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00623-0 · Cited by 57
Bate, N., Savva, C. G., Moody, P. C. E., Brown, E. A., Evans, S. E., Ball, J. K., Schwabe, J. W. R., Sale, J. E., & Brindle, N. P. J. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010733 · Cited by 52
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
Wrobel, A. G., Benton, D. J., Hussain, S., Harvey, R., Martin, S. R., Roustan, C., Rosenthal, P. B., Skehel, J. J., & Gamblin, S. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19146-5 · Cited by 57
Self-citationMolecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge
Zhu, C., He, G., Yin, Q., Zeng, L., Ye, X., Shi, Y., & Xu, W. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27132 · Cited by 61
Toelzer, C., Gupta, K., Yadav, S. K. N., Hodgson, L. R., Williamson, M. K., Buzas, D., Borucu, U., Powers, K. T., Stenner, R., Vasileiou, K., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9179 · Cited by 49
Osman, E. E. A., Rehemtulla, A., & Neamati, N. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00518 · Cited by 54
Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
Ghimire, D., Han, Y., & Lu, M. (2022) · Viruses · doi:10.3390/v14061255 · Cited by 44
Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
Pak, A. J., Yu, A., Ke, Z., Briggs, J. A. G., & Voth, G. A. (2022) · Nature Communications · doi:10.1038/s41467-022-28654-5 · Cited by 47
Islam, A., Ferdous, J., Islam, S., Sayeed, M. A., Choudhury, S. D., Saha, O., Hassan, M. M., & Shirin, T. (2021) · Viruses · doi:10.3390/v13101908 · Cited by 52
Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
Upadhya, S. W., Rehman, J., Malik, A. B., & Chen, S. (2021) · Physiology · doi:10.1152/physiol.00033.2021 · Cited by 54
The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?
Guo, S., Liu, K., & Zheng, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59137 · Cited by 46
Seow, J., Khan, H., Rosa, A., Calvaresi, V., Graham, C., Pickering, S., Pye, V. E., Cronin, N., Huettner, I., Malim, M. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111276 · Cited by 41
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Yao, Z., Zhang, L., Duan, Y., Tang, X., & Lü, J. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106121 · Cited by 49
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Park, Y., Liu, C., Lee, J., Brown, J. T., Ma, C., Liu, P., Gen, R., Xiong, Q., Zepeda, S. K., Stewart, C., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.032 · Cited by 47
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
Mehra, R., & Kepp, K. P. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00433 · Cited by 45
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
Roelle, S. M., Shukla, N., Pham, A. T., Bruchez, A. M., & Matreyek, K. A. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001738 · Cited by 40
Profiles of current COVID-19 vaccines
Heinz, F. X., & Stiasny, K. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01835-w · Cited by 45
Sakib, M. M. H., Nishat, A. A., Islam, M. T., Uddin, M. A. R., Iqbal, M. S., Hossen, F. F. B., Ahmed, M. I., Bashir, M. S., Hossain, T., Tohura, U. S., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104759 · Cited by 44
Al-Karmalawy, A. A., Soltane, R., Elmaaty, A. A., Tantawy, M. A., Antar, S. A., Yahya, G., Chrouda, A., Pashameah, R. A., Mustafa, M., Mraheil, M. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9111317 · Cited by 43
Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
Wrobel, A. G. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102619 · Cited by 48
Self-citationQin, Z., Zhang, K., He, P., Zhang, X., Xie, M., Fu, Y., Gu, C., Zhu, Y., Tong, A., Wei, H., et al. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01304-z · Cited by 44
van Oosten, L., Altenburg, J. J., Fougeroux, C. E., Geertsema, C., van den End, F., Evers, W. A. C., Westphal, A. H., Lindhoud, S., van den Berg, W., Swarts, D. C., et al. (2021) · mBio · doi:10.1128/mbio.01813-21 · Cited by 43
Cheng, Y. W., Chao, T., Li, C., Wang, S.-H., Kao, H., Tsai, Y., Wang, H., Hsieh, C.-L., Lin, Y.-Y., Chen, P., et al. (2021) · mBio · doi:10.1128/mbio.00587-21 · Cited by 41
Zhou, T., Tsybovsky, Y., Olia, A. S., Gorman, J., Rapp, M., Cerutti, G., Chuang, G., Katsamba, P. S., Nazzari, A. F., Sampson, J. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.04.187989 · Cited by 48
The Importance of Research on the Origin of SARS-CoV-2
Lundstrom, K. H., Seyran, M., Pizzol, D., Adadi, P., El‐Aziz, T. M. A., Hassan, S. S., Soares, A. G., Kandimalla, R. J. L., Tambuwala, M. M., Aljabali, A. A. A., et al. (2020) · Viruses · doi:10.3390/v12111203 · Cited by 43
Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
De, P., Chakraborty, I., Karna, B., & Mazumder, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173977 · Cited by 46
Mikolajek, H., Weckener, M., Brotzakis, Z. F., Huo, J., Dalietou, E. V., Bas, A. L., Sormanni, P., Harrison, P. J., Ward, P. N., Truong, S. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205412119 · Cited by 39
Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body
Kopańska, M., Barnaś, E., Błajda, J., Kuduk, B., Łagowska, A., & Banaś-Ząbczyk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084178 · Cited by 45
Spike residue 403 affects binding of coronavirus spikes to human ACE2
Zech, F., Schniertshauer, D., Jung, C., Herrmann, A., Cordsmeier, A., Xie, Q., Nchioua, R., Bozzo, C. P., Volčič, M., Koepke, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27180-0 · Cited by 47
Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein
Zuzic, L., Samsudin, F., Shivgan, A. T., Raghuvamsi, P. V., Marzinek, J. K., Boags, A. T., Pedebos, C., Tulsian, N. K., Warwicker, J., MacAry, P. A., et al. (2022) · Structure · doi:10.1016/j.str.2022.05.006 · Cited by 41
Park, S. B., Khan, M., Chiliveri, S. C., Hu, X., Irvin, P., Leek, M., Grieshaber, A., Hu, Z., Jang, E. S., Bax, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04923-x · Cited by 40
Wang, Q., Guo, Y., Bowen, A. D., Mellis, I. A., Valdez, R., Gherasim, C., Gordon, A. L., Liu, L., & Ho, D. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.26.568730 · Cited by 40
Ahiakpa, J. K., Cosmas, N. T., Anyiam, F. E., Enalume, K. O., Lawan, I., Gabriel, I. B., Oforka, C. L., Dahir, H. G., Salisu, T. F., Nwobodo, M. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268230 · Cited by 41
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
Tan, Z. W., Tee, W.-V., Samsudin, F., Guarnera, E., Bond, P. J., & Berezovsky, I. N. (2022) · Structure · doi:10.1016/j.str.2021.12.011 · Cited by 38
Martin, D. P., Lytras, S., Lucaci, A. G., Maier, W., Grüning, B. A., Shank, S. D., Weaver, S., MacLean, O. A., Orton, R. J., Lemey, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476382 · Cited by 40
Tan, C. C. S., Trew, J., Peacock, T. P., Mok, K. Y., Hart, C., Lau, K., Ni, D., Orme, C. D. L., Ransome, E., Pearse, W. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38717-w · Cited by 34
Should we discount the laboratory origin of COVID-19?
Segreto, R., Deigin, Y., McCairn, K., Sousa, A., Sirotkin, D., Sirotkin, K. M., Couey, J. J., Jones, A., & Zhang, D. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01211-0 · Cited by 42
Quaglia, F., Salladini, E., Carraro, M., Minervini, G., Tosatto, S. C. E., & Mercier, P. L. (2022) · FEBS Journal · doi:10.1111/febs.16379 · Cited by 36
de Hoffer, A., Vatani, S., Cot, C., Cacciapaglia, G., Chiusano, M. L., Cimarelli, A., Conventi, F., Giannini, A., Hohenegger, S., & Francesco Sannino, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12442-8 · Cited by 39
Ou, X., Xu, G. Z., Li, P., Liu, Y., Zan, F., Liu, P., Hu, J., Lu, X., Dong, S., Zhou, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00581-9 · Cited by 35
Wang, P., Lau, S.-Y., Deng, S., Chen, P., Mok, B. W.-Y., Zhang, J., Lee, A. C.-Y., Chan, K., Tam, R. C.-Y., Xu, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23166-0 · Cited by 37
Higashikuni, Y., Liu, W., Obana, T., & Sata, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112081 · Cited by 38
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
Mlčochová, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Mishra, S., Whittaker, C., Mellan, T. A., Ferreira, I., Datir, R. P., et al. (2021) · Greater South Information System · doi:10.60692/dy28a-h7650 · Cited by 44
Targeting Crucial Host Factors of SARS-CoV-2
Tharappel, A. M., Samrat, S. K., Li, Z., & Li, H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00456 · Cited by 36
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
Khan, H., Winstone, H., Jiménez-Guardeño, J. M., Graham, C., Doores, K. J., Goujon, C., Matthews, D. A., Davidson, A. D., Rihn, S. J., Palmarini, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009820 · Cited by 34
Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein
Zhang, S., Go, E. P., Ding, H., Anang, S., Kappes, J. C., Desaire, H., & Sodroski, J. (2021) · Journal of Virology · doi:10.1128/jvi.01626-21 · Cited by 39
Adaptive Evolution of the Spike Protein in Coronaviruses
Tang, X., Qian, Z., Lu, X., & Lü, J. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad089 · Cited by 36
Li, P. S., Guo, R., Liu, Y., Zhang, Y., Hu, J., Ou, X., Mi, D., Chen, T., Mu, Z., Han, Y., et al. (2021) · 中国科学通报:英文版 · doi:10.1016/j.scib.2021.01.011 · Cited by 33
Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2
Gupta, K., Toelzer, C., Williamson, M. K., Shoemark, D. K., Oliveira, A. S. F., Matthews, D. A., Almuqrin, A., Staufer, O., Yadav, S. K. N., Borucu, U., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27881-6 · Cited by 37
Dicken, S. J., Murray, M. J., Thorne, L., Reuschl, A., Forrest, C., Ganeshalingham, M., Muir, L., Kalemera, M. D., Palor, M., McCoy, L. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.22.436468 · Cited by 30
Insights on the mutational landscape of the SARS-CoV-2 Omicron variantPreprint
Miller, N. L., Clark, T., Raman, R., & Sasisekharan, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.06.471499 · Cited by 35
Host range, transmissibility and antigenicity of a pangolin coronavirus
Hou, Y. J., Chiba, S., Leist, S. R., Meganck, R. M., Martinez, D. R., Schäfer, A., Catanzaro, N., Sontake, V., West, A., Edwards, C. E., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01476-x · Cited by 36
Engineered disulfide reveals structural dynamics of locked SARS-CoV-2 spike
Qu, K., Chen, Q., Ciazynska, K. A., Liu, B., Zhang, X., Wang, J., He, Y., Guan, J., He, J., Liu, T., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010583 · Cited by 33
Halfmann, P., Minor, N. R., Haddock, L. A., Maddox, R., Moreno, G. K., Braun, K. M., Baker, D. A., Riemersa, K. K., Prasad, A., Alman, K. J., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac104 · Cited by 36
Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein
Feng, Z., Huang, J., Baboo, S., Diedrich, J. K., Bangaru, S., Paulson, J. C., Yates, J. R., Yuan, M., Wilson, I. A., & Ward, A. B. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115941 · Cited by 33
Xu, Z., Kang, X., Han, P., Du, P., Li, L., Zheng, A., Deng, C., Qi, J., Zhao, X., Wang, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31276-6 · Cited by 31
Rangel, M. A., Dolan, P., Taguwa, S., Xiao, Y., Andino, R., & Frydman, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304667120 · Cited by 31
EMDA: A Python package for Electron Microscopy Data Analysis
Warshamanage, R., Yamashita, K., & Murshudov, G. N. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107826 · Cited by 33
Feline infectious peritonitis epizootic caused by a recombinant coronavirus
Attipa, C., Warr, A., Epaminondas, D., O’Shea, M., Hanton, A. J., Fletcher, S., Malbon, A. J., Lyraki, M., Hammond, R., Hardas, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09340-0 · Cited by 32
Modeling in the Time of COVID-19: Statistical and Rule-based Mesoscale Models
Nguyen, N., Strnad, O., Klein, T. R., Luo, D., Alharbi, R., Wonka, P., Maritan, M., Mindek, P., Autin, L., Goodsell, D. S., et al. (2020) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2020.3030415 · Cited by 34
Freidel, M. R., & Armen, R. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246181 · Cited by 34
Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites
Liu, X., Wu, Q., & Zhang, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649314 · Cited by 32
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry
Tong, L., Wang, L., Liao, S., Xiao, X., Qu, J. T., Wu, C., Zhu, Y., Tai, W., Huang, Y., Wang, P., et al. (2022) · mBio · doi:10.1128/mbio.01485-22 · Cited by 32
Vásquez, V., & Orozco, J. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04237-7 · Cited by 32
A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
Wierbowski, S. D., Liang, S., Liu, Y., Chen, Y., Gupta, S., Andre, N. M., Lipkin, S. M., Whittaker, G. R., & Yu, H. (2021) · Nature Methods · doi:10.1038/s41592-021-01318-w · Cited by 32
Liu, P., Yue, C., Meng, B., Xiao, T., Yang, S., Liu, S., Jian, F., Zhu, Q., Yu, Y., Ren, Y.-Y., et al. (2024) · National Science Review · doi:10.1093/nsr/nwae206 · Cited by 33
Novel SARS-CoV-2 encoded small RNAs in the passage to humans
Merino, G. A., Raad, J., Bugnon, L. A., Yones, C., Kamenetzky, L., Claus, J. D., Ariel, F., Milone, D. H., & Stegmayer, G. S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa1002 · Cited by 31
Limited cross-species virus transmission in a spatially restricted coral reef fish community
Costa, V. A., Bellwood, D. R., Mifsud, J. C. O., Brussel, K. V., Geoghegan, J. L., Holmes, E. C., & Harvey, E. (2023) · Virus Evolution · doi:10.1093/ve/vead011 · Cited by 30
Yevsieieva, L. V., Lohachova, K. O., Kyrychenko, A. V., Kovalenko, S. М., Ivanov, V. V., & Kalugin, O. N. (2023) · RSC Advances · doi:10.1039/d3ra06479d · Cited by 38
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidatesPreprint
Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., Villemagne, D., Paladino, M., Hospodarsch, T., Neculcea, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.256339 · Cited by 30
Antony, P., & Vijayan, R. (2021) · Biomolecules · doi:10.3390/biom11081244 · Cited by 31
Jensen, J. L., Sankhala, R. S., Dussupt, V., Bai, H., Hajduczki, A., Lal, K. G., Chang, W. C., Martinez, E. J., Peterson, C. E., Golub, E. S., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01596-22 · Cited by 29
SARS-CoV-2: Zoonotic origin of pandemic coronavirus
Vilček, Š. (2020) · Acta Virologica · doi:10.4149/av_2020_302 · Cited by 29
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
Xu, S., Wang, Y., Wang, Y., Zhang, C., Qin, H., Gu, C., Xu, R., Wang, T., Yang, Y. P., Zang, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2024455 · Cited by 28
Heme binding to the SARS-CoV-2 spike glycoprotein
Freeman, S. L., Oliveira, A. S. F., Gallio, A. E., Rosa, A., Simitakou, M. K., Arthur, C. J., Mulholland, A. J., Cherepanov, P., & Raven, E. L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105014 · Cited by 30
Dimonaco, N. J., Salavati, M., & Shih, B. B.-J. (2020) · Viruses · doi:10.3390/v13010049 · Cited by 29
Pillalamarri, N., Abdullah, A., Ren, G., Khan, L., Ullah, A., Jonnakuti, S. T., & Ullah, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101095 · Cited by 29
The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
López-Cortés, G. I., Palacios-Pérez, M., Veledíaz, H. F., Hernández-Aguilar, M. M., López-Hernández, G. R., Zamudio, G. S., & José, M. V. (2022) · Vaccines · doi:10.3390/vaccines10060864 · Cited by 26
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
Afshar, Z. M., Pirzaman, A. T., Karim, B., Anaraki, S. R., Hosseinzadeh, R., Pireivatlou, E. S., Babazadeh, A., Hosseinzadeh, D., Miri, S. R., Sio, T. T. W., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030559 · Cited by 29
González-Rodríguez, E., Zol-Hanlon, M. I., Bineva‐Todd, G., Marchesi, A., Skehel, M. J., Mahoney, K. E., Roustan, C., Borg, A., Vagno, L. D., Kjær, S., et al. (2023) · ACS Central Science · doi:10.1021/acscentsci.2c01349 · Cited by 28
Self-citationA Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
Yoshimoto, F. K. (2021) · The Protein Journal · doi:10.1007/s10930-021-09967-8 · Cited by 28
Shrivastava, T., Singh, B., Rizvi, Z. A., Verma, R., Goswami, S., Vishwakarma, P., Jakhar, K., Sonar, S., Mani, S., Bhattacharyya, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641447 · Cited by 26
Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review
Jelinek, H. F., Mousa, M., Alefishat, E. A., Osman, W. M., Spence, I., Bu, D., Feng, S. F., Byrd, J. H., Magni, P. A., Sahibzada, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.644414 · Cited by 28
Effective chimeric antigen receptor T cells against SARS-CoV-2
Guo, X., Kazanova, A., Thurmond, S., Saragovi, H. U., & Rudd, C. E. (2021) · iScience · doi:10.1016/j.isci.2021.103295 · Cited by 29
Metadata
- Authors
- Wrobel, A. G., Benton, D. J., Xu, P., Roustan, C., Martin, S. R., Rosenthal, P. B., Skehel, J. J., & Gamblin, S. J.
- Affiliations
- The Francis Crick Institute (GB)
- Sun Yat-sen University (CN)
- Corresponding author
- Wrobel, Antoni G.
- Benton, Donald J.
- ORCID
- Venue
- Nature Structural & Molecular Biology
- Published
- 2020-07-09
- Volume
- 27
- Issue
- 8
- Pages
- 763-767
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- PMC
- PMC7610980
- OpenAlex
- W3040801746
- Cited by
- 544
- References
- 37
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 53 · 2023: 82 · 2022: 129 · 2021: 180 · 2020: 48
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-08-26)
- Open access
- bronze
- doi.org
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK (FC001078, FC001143)
- Wellcome Trust (FC001078, FC001143)
- RCUK | Medical Research Council (FC001078, FC001143)
- Sun Yat-sen University
- 100 Top Talents Program of Sun Yat-sen University & the Sanming Project of Medicine in Shenzhen
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- SARS-CoV-2, RaTG13, spike protein, furin cleavage, ACE2 binding, protein stability, bat coronaviruses, viral evolution, SARS-CoV-2 origin, receptor binding affinity
- MeSH terms
- Protein Conformation, alpha-Helical, Protein Conformation, beta-Strand, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Binding Sites, Chiroptera, Humans, Peptidyl-Dipeptidase A, Models, Molecular, Pneumonia, Viral, Protein Binding, Receptors, Virus, Recombinant Proteins, Gene Expression, Coronavirus Infections, Evolution, Molecular, Protein Isoforms, Cryoelectron Microscopy, Structural Homology, Protein, Furin, Protein Interaction Domains and Motifs, Host-Pathogen Interactions, Protein Stability, HEK293 Cells, Pandemics, Proteolysis, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review